EMP2 is a novel therapeutic target for endometrial cancer stem cells

Previous studies have suggested that overexpression of the oncogenic protein epithelial membrane protein-2 (EMP2) correlates with endometrial carcinoma progression and ultimately poor survival from disease. To understand the role of EMP2 in the etiology of disease, gene analysis was performed to sho...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiyohara, Meagan H., Dillard, Christen, Tsui, Jessica, Kim, Sara Ruth, Lu, Jianyi, Sachdev, Divya, Goodglick, Lee, Tong, Maomeng, Torous, Vanda Farahmand, Aryasomayajula, Chinmayi, Wang, Wei, Najafzadeh, Parisa, Gordon, Lynn K., Braun, Jonathan, McDermott, Sean, Wicha, Max S., Wadehra, Madhuri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648618/
https://www.ncbi.nlm.nih.gov/pubmed/28604744
http://dx.doi.org/10.1038/onc.2017.142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648618/
https://www.ncbi.nlm.nih.gov/pubmed/28604744
http://dx.doi.org/10.1038/onc.2017.142

Ejemplares similares